-
Uncategorized3 days ago
Chikungunya Vaccine Development in Africa Accelerated by ACT-CHIK
Institut Pasteur is launching ACT-CHIK (Accelerating Clinical Trials for CHIKungunya Vaccine in Africa), a four-year research project funded by the Global Health EDCTP3 Joint Undertaking under...
-
Uncategorized3 days ago
ADA: Novo boasts deep pipeline, ‘breadth of assets’ after analysts award Lilly weight loss gold
Novo Nordisk and Eli Lilly presented data extolling the benefits of their relative weight loss therapies in obesity-linked indications, while analysts at BMO Capital Markets were...
-
Uncategorized3 days ago
Roche stakes $700M on Nurix’s protein-degrading drug
Potentially worth up to $2.3 billion, the collaboration is a bet that drugs able to eliminate the “BTK” enzyme will prove superior to existing medicines that...
-
Uncategorized3 days ago
J&J glows with $1B buyout of Firefly and its degrader platform tech
The acquisition gives Johnson & Johnson access to Firefly Bio’s next-gen platform designed to create degrader antibody conjugates that can crack the tricky KRAS cancer target.
-
Uncategorized3 days agoTango data add to growing momentum for pancreatic cancer drugs
A combination involving Tango’s experimental therapy appeared to boost response rates in a small clinical trial well beyond what would be expected, sparking a share surge....
-
Uncategorized3 days agoIncyte to buy blood disorder drug in possibly $2B deal
Acquiring Vega Therapeutics, an offshoot of "hub-and-spoke" biotech Star Therapeutics, would give Incyte a medicine that’s in late-stage testing and designed to control bleeding. Read More
-
Uncategorized3 days ago
City aims to lay foundation for RNAi renaissance with nearly $100M series B
Looking to spark an antibody-like revolution for RNA interference medicines, City Therapeutics has landed a nearly $100 million series B to fund a clinical push and...
-
Uncategorized3 days agoCiteSentinel Launched to Detect and Prevent AI Hallucinations in Legal Citations
Legal tech startup BrentWorks reports that it has launched CiteSentinel, a dedicated platform built specifically to detect and prevent AI hallucinations in legal citations, including those...
-
Uncategorized3 days ago
CRISPR Shreds Undruggable Cancer Cells with Precision
When Jingkun Zeng, PhD, joined the lab of Nobel laureate, Jennifer Doudna, PhD, as a postdoctoral researcher in 2024, he was not interested in applying CRISPR...
-
Uncategorized3 days agoSTAT+: UnitedHealthcare’s lactation billing feud, and fake strokes
This is the online version of STAT’s weekly email newsletter Health Care Inc. Sign up here. I live in northwest Indiana, and it appears the Chicago Bears...
An obesity drug deep-dive, and peptides move mainstream
RFK Jr. claims his calendar is publicly available. We’ve been trying to get it for a year
